New Drugs for HIV Treatment and Prevention

Roy M. Gulick, MD, MPH
Rochelle Belfer Professor in Medicine
Chief, Division of Infectious Diseases
Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY

Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc. Copyright © 2024. All rights reserved.

Download Article PDF/Slides    

How to Obtain CME Credit:

Top of page

Click here to take the CME Evaluation and Post-Meeting Survey

About the Presenter:

Top of page

Dr. Gulick’s research interests include designing, conducting and analyzing clinical trials to refine antiretroviral therapy strategies for HIV treatment and prevention and assess agents with new mechanisms of action. He currently serves as Principal Investigator of the Cornell-New Jersey HIV Clinical Trials Unit of the ACTG and the HIV Prevention Trials Network (HPTN), sponsored by the NIH.

Learning Objectives:

Top of page

At the completion of this educational activity learners will:
1. Learn about new formulations of existing antiretroviral drugs.
2. Learn about investigational drugs in existing antiretroviral drug classes.
3. Learn about investigational drugs with new mechanisms of action.

CME Information:

Top of page

This CME activity has approved for AMA PRA Category 1 Credit™ for October 22, 2024, as a live activity. This activity will also be available as an enduring activity from October 29, 2024, through October 21, 2027.

The target audience is all physicians, NPs and PAs involved in or interested in HIV education.

This online video and post-activity evaluation are one hour in length.

Accreditation Statement:

Top of page

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement:

Top of page

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure Statement:

Top of page

Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices, or services may be discussed in the content of a CME activity.

- Dr. James F. Braun (Course Director/Program Planner) has no relevant financial relationships to disclose.
- Dr. Kathryn Anastos, MD (Moderator) has no relevant financial relationships to disclose.
- Dr. Roy M. Gulick, MD, MPH (Presenter) has no relevant financial relationships to disclose. Dr. Gulick submitted his slides in advance for adequate peer review and supported his presentation and clinical recommendations with the best available evidence from the medical literature.

Financial Support:

Top of page

This PRN CME activity is funded in part by unrestricted educational grants from Gilead Sciences and ViiV Healthcare and by a generous charitable contribution from Northwell Health Center for AIDS Research & Treatment.